2022 Expert Speaker Faculty

Speakers

Expand/Collapse

Muthiah Manoharan
Oligonucleotide Chemist for Delivery of Nucleic Acid Therapeutics
Alnylam Pharmaceuticals

Day One

Thursday 13th December 2018

2:30 pm | Roundtable Discussion: The interface of RNA modality/particle with delivery systems: How the two should work together towards durable, effective & targeted therapies?

8:30 am | Breakfast Panel: What are Next Generation Non-Viral Delivery Systems for RNA Delivery?

Ramsey Majzoub
Senior Principal Scientist
Intellia Therapeutics

Jeonghwan Kim
Postdoctoral Scholar
Oregon State University

Day Two

Thursday 13th December 2018

12:00 pm | Inhalable Lipid Nanoparticles for Messenger RNA Therapeutics

Heinrich Haas
Vice President Formulation & Drug Delivery
BioNTech

Day One

Thursday 13th December 2018

9:30 am | Delivery Approaches for Next Generation RNA Therapeutics

Larry Brown
Research & Development, Executive Vice President & Chief Scientific Officer
Noveome Biotherapeutics

Siddarth Patel
Associate Director
Senda Biosciences

Shawn Davis
Executive Director, Drug Delivery
AstraZeneca

Day One

Thursday 13th December 2018

8:30 am | Breakfast Panel: What are Next Generation Non-Viral Delivery Systems for RNA Delivery?

Patrick Baumhof
Senior Vice President of Technology
CureVac

Day One

Thursday 13th December 2018

10:00 am | mRNA Therapeutics for Treatment of Liver Fibrosis

8:30 am | Breakfast Panel: What are Next Generation Non-Viral Delivery Systems for RNA Delivery?

Hamideh Parhiz
Research Assistant, Professor of Medicine
University of Pennsylvania

Day One

Thursday 13th December 2018

11:30 am | Targeted LNP-mRNA Platform for In Vivo Cellular Reprogramming

8:30 am | Breakfast Panel: What are Next Generation Non-Viral Delivery Systems for RNA Delivery?

Xiaoyong Lu
Director of Chemistry & Oligonucleotide Delivery
Sirnaomics

Day One

Thursday 13th December 2018

4:00 pm | Polypeptide Nanoparticle (PNP) & Peptide Docking Vehicle (PDoV) for siRNA Delivery

Day Two

Thursday 13th December 2018

9:30 am | Panel Discussion: Modifying RNA Payload Formulations to Increase Stability during Delivery

Mohamed ElSayed
Chief Technical Officer
RVAC Medicines

Day One

Thursday 13th December 2018

8:30 am | Breakfast Panel: What are Next Generation Non-Viral Delivery Systems for RNA Delivery?

Olga Villamizar
Principal Scientist
Pfizer

Day Two

Thursday 13th December 2018

2:30 pm | Engineer Exosome for Drug Delivery

AJ Bergman
Chief Executive Officer
Capricor Therapeutics

Day One

Thursday 13th December 2018

8:20 am | Chair’s Opening Remarks

Day Two

Thursday 13th December 2018

9:30 am | Panel Discussion: Modifying RNA Payload Formulations to Increase Stability during Delivery

Alena Ivanova
Postdoctoral Fellow
AstraZeneca

Day Two

Thursday 13th December 2018

1:30 pm | Engineering Extracellular Vesicles for the Delivery of Gene Editing Tools

Ashish Sarode
Associate Director Delivery & Formulation
Sanofi

Day One

Thursday 13th December 2018

12:00 pm | Next Generation mRNA LNPs for Liver Delivery

Day Two

Thursday 13th December 2018

9:30 am | Panel Discussion: Modifying RNA Payload Formulations to Increase Stability during Delivery

Benjamin Bleier
Associate Professor & Director of Translational Research; Director of Endoscopic Skull Base Surgery & Director (Co) of Center for Orbital Surgery & Claire and John Bertucci Chair in OHNS
Harvard Medical School

Bulent Ozpolat
Professor
Houston Methodist Research Institute

Day One

Thursday 13th December 2018

1:30 pm | Development & Delivery of RNA-Based Therapeutics for Breast Cancer

Curtis Dobrowolski
Co-Founder
Nava Therapeutics

Day One

Thursday 13th December 2018

4:30 pm | Nanoparticle Single-Cell Multiomic Readouts Reveal that Cell Heterogeneity Influences Lipid Nanoparticle-Mediated mRNA Delivery

Daniel Anderson
Professor
MIT

Day Two

Thursday 13th December 2018

9:00 am | Non-Viral Delivery of RNA for Gene Therapy & Editing

Jay Sarkar
Visiting Scholar
Stanford University

John Lewis
Chief Executive Officer
Entos Pharmaceuticals

Day Two

Thursday 13th December 2018

11:30 am | Exploring a Next-Generation Delivery Platform for Targeted Payload Delivery:
Fusogenix Proteolipid Vehicle (PLV)

9:30 am | Panel Discussion: Modifying RNA Payload Formulations to Increase Stability during Delivery

Mansoor Amiji
Professor of Pharmaceutical Sciences, & Professor of Chemical Engineering
Northeastern University

Nelly Valkov
Scientist II
Vesigen Therapeutics

Day Two

Thursday 13th December 2018

2:00 pm | RNA Packaging & Delivery via ARMMs (ARrestin-Domain 1 Mediated Microvesicles) Technology

Poulami Talukder
Senior Scientist
Tiba Biotech

Day One

Thursday 13th December 2018

2:00 pm | Tiba’s RNABL™ Platform: An Alternative to Conventional Lipid-Based Delivery Systems

Shayak Samaddar
Research Scientist
Eli Lilly

Day One

Thursday 13th December 2018

2:30 pm | Roundtable Discussion: The interface of RNA modality/particle with delivery systems: How the two should work together towards durable, effective & targeted therapies?

Day Two

Thursday 13th December 2018

3:00 pm | Chair’s Closing Remarks

8:50 am | Chair’s Opening Remarks

Tatiana Bronich
Professor
Northeastern University